BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Divis Laboratories Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
532488
ISIN Demat
INE361B01024
Book Value (Rs)
561.0868795
NSE Symbol
DIVISLAB
Divident Yield %
0.45
Market Cap
(Rs In Cr.)
174,885
P/E (TTM)
74.86
EPS (TTM)
88
Face Value
(Rs)
2
Back
Divi's Laboratories consolidated net profit rises 26.74% in the June 2025 quarter
08-Aug-25   Hrs IST

Net profit of Divi's Laboratories rose 26.74% to Rs 545.00 crore in the quarter ended June 2025 as against Rs 430.00 crore during the previous quarter ended June 2024. Sales rose 13.79% to Rs 2410.00 crore in the quarter ended June 2025 as against Rs 2118.00 crore during the previous quarter ended June 2024.

ParticularsQuarter Ended
Jun. 2025Jun. 2024% Var.
Sales2410.002118.00 14
OPM %30.2529.37 -
PBDT845.00701.00 21
PBT733.00604.00 21
NP545.00430.00 27

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)